Malignant Multiple Neoplasms in Head and Neck Squamous Cell Carcinoma

被引:5
作者
Lopez Molla, Celia [1 ]
Estelles Ferriol, Enrique [1 ]
Carrasco Llatas, Marina [1 ]
Seijas Rosales, Teresa [1 ]
Morales Suarez-Varela, Maria [2 ]
Dalmau Galofre, Jose [1 ]
机构
[1] Hosp Univ Dr Peset, Serv Otorrinolaringol, Valencia, Spain
[2] Hosp Univ Dr Peset, Unidad Invest, Valencia, Spain
来源
ACTA OTORRINOLARINGOLOGICA ESPANOLA | 2008年 / 59卷 / 09期
关键词
Multiple malignant neoplasms; Head and neck squamous cell carcinoma; Metachronous; Second primary tumours;
D O I
10.1016/S0001-6519(08)75113-6
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Introduction: The incidence of multiple malignant neoplasms in the upper aerodigestive tract is high and ranges from 7% to 20%. We make a retrospective study to evaluate the incidence of multiple malignant neoplasms in head and neck squamous cell carcinomas, their main characteristics and survival. Material and method: We studied 103 multiple malignant neoplasms from an oncological database of 1330 patients with head and neck squamous cell carcinomas. We use the SPSS v15 for analysis of the results. Results: The incidence of multiple malignant neoplasms in our series is 7.73 %. Tumours of the hypopharynx are the primary tumours most often associated with multiple malignant neoplasms (21.34 %), followed by tumours of the oropharynx (15.38 %). Lung tumours are the multiple malignant neoplasms most often associated (29.03 %). The 5- year global survival is 33 % from diagnosis of the second primary tumour, 78.02 % of which are metachronous with an average of 40 months between the diagnosis of the primary tumour and the presentation of the second tumour. Conclusions: Multiple malignant neoplasms are very frequent in the head and neck area which shows the importance of thorough regular check- ups of these patients as the presence of multiple malignant neoplasms considerably worsens the prognosis.
引用
收藏
页码:427 / 432
页数:6
相关论文
共 37 条
[1]   Second primary tumors in head and neck cancer [J].
Alvarez Marcos, C. A. ;
Llorente Pendas, J. L. ;
Franco Gutierrez, V. ;
Hermsen, M. A. J. A. ;
Cuesta Albalad, M. P. ;
Fernandez Espina, H. ;
Suarez Nieto, C. .
ACTA OTORRINOLARINGOLOGICA ESPANOLA, 2006, 57 (10) :462-466
[2]   Tumour Recurrence in Squamous Head and Neck Cancer [J].
Alvarez Marcos, Cesar Antonio ;
Llorente Pendas, Jose Luis ;
Franco Gutierrez, Virginia ;
Fernandez Espina, Humberto ;
Alonso Guervos, Marta ;
Suarez Nieto, Carlos ;
Hermsen, Mario .
ACTA OTORRINOLARINGOLOGICA ESPANOLA, 2007, 58 (04) :156-163
[3]  
Alvarez Perez RM, 2006, ACTA OTORRINOLARINGO, V57, P134
[4]  
Berj J, 1970, JNCI-J NATL CANCER I, V44, P263
[5]   2ND PRIMARIES IN CASES OF CANCER OF LARYNX [J].
BROWN, M .
JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1978, 92 (11) :991-996
[6]   Prognostic significance of serum p53 protein and p53 antibody in patients with surgical treatment for head and neck squamous cell carcinoma [J].
Chow, V ;
Yuen, APW ;
Lam, KY ;
Ho, WK ;
Wei, WI .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2001, 23 (04) :286-291
[7]  
Cohn A M, 1980, Am J Otolaryngol, V1, P411, DOI 10.1016/S0196-0709(80)80022-6
[8]  
Davidson BJ, 1996, HEAD NECK-J SCI SPEC, V18, P512, DOI 10.1002/(SICI)1097-0347(199611/12)18:6<512::AID-HED5>3.0.CO
[9]  
2-5
[10]   Multiple primary malignant tumors in patients with head and neck cancer: Results of a prospective study and future perspectives [J].
Dhooge, IJ ;
De Vos, M ;
Van Cauwenberge, PB .
LARYNGOSCOPE, 1998, 108 (02) :250-256